Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis

BACKGROUND: In the first-line treatment of advanced non-small cell lung cancer (NSCLC), for those patients with negative PD-L1 expression, which treatment strategy has the better efficacy and safety between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors (ICIs) is sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiaqi, Chen, Yingjie, Hu, Fan, Qiang, Huiping, Chang, Qing, Qian, Jialin, Shen, Yinchen, Cai, Yong, Chu, Tianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746688/
https://www.ncbi.nlm.nih.gov/pubmed/36523992
http://dx.doi.org/10.3389/fonc.2022.1001503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746688/
https://www.ncbi.nlm.nih.gov/pubmed/36523992
http://dx.doi.org/10.3389/fonc.2022.1001503

Ejemplares similares